Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression.

Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J.

Cancer Lett. 2013 Jun 10;333(2):213-21. doi: 10.1016/j.canlet.2013.01.033. Epub 2013 Jan 24.

PMID:
23354591
2.

Re: Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression.

Atala A.

J Urol. 2013 Dec;190(6):2306. doi: 10.1016/j.juro.2013.08.057. Epub 2013 Aug 30. No abstract available.

PMID:
24209571
3.

miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling.

Guo Y, Ying L, Tian Y, Yang P, Zhu Y, Wang Z, Qiu F, Lin J.

FEBS J. 2013 Sep;280(18):4531-8. doi: 10.1111/febs.12417. Epub 2013 Jul 25.

4.

Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma.

Wu Y, Zhang L, Zhang L, Wang Y, Li H, Ren X, Wei F, Yu W, Liu T, Wang X, Zhou X, Yu J, Hao X.

Int J Oncol. 2015;46(6):2586-94. doi: 10.3892/ijo.2015.2976. Epub 2015 Apr 22.

PMID:
25901533
5.

TGF-β-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12.

Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F, Liu Y.

Clin Cancer Res. 2014 Mar 15;20(6):1531-41. doi: 10.1158/1078-0432.CCR-13-1455. Epub 2014 Jan 21.

6.

EZH2 in Bladder Cancer, a Promising Therapeutic Target.

Martínez-Fernández M, Rubio C, Segovia C, López-Calderón FF, Dueñas M, Paramio JM.

Int J Mol Sci. 2015 Nov 13;16(11):27107-32. doi: 10.3390/ijms161126000. Review.

7.

Long noncoding RNA-EBIC promotes tumor cell invasion by binding to EZH2 and repressing E-cadherin in cervical cancer.

Sun NX, Ye C, Zhao Q, Zhang Q, Xu C, Wang SB, Jin ZJ, Sun SH, Wang F, Li W.

PLoS One. 2014 Jul 9;9(7):e100340. doi: 10.1371/journal.pone.0100340. eCollection 2014.

8.

MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.

Xia H, Ooi LL, Hui KM.

PLoS One. 2012;7(9):e44206. doi: 10.1371/journal.pone.0044206. Epub 2012 Sep 4. Erratum in: PLoS One. 2012;7(9). doi:10.1371/annotation/1be2a62e-45a1-4c13-9a8d-f265005a21e0.

9.

LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer.

Wang D, Ding L, Wang L, Zhao Y, Sun Z, Karnes RJ, Zhang J, Huang H.

Oncotarget. 2015 Dec 1;6(38):41045-55. doi: 10.18632/oncotarget.5728.

10.

EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer.

Han T, Jiao F, Hu H, Yuan C, Wang L, Jin ZL, Song WF, Wang LW.

Oncotarget. 2016 Mar 8;7(10):11194-207. doi: 10.18632/oncotarget.7156.

11.

EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.

Sun M, Liu XH, Lu KH, Nie FQ, Xia R, Kong R, Yang JS, Xu TP, Liu YW, Zou YF, Lu BB, Yin R, Zhang EB, Xu L, De W, Wang ZX.

Cell Death Dis. 2014 Jun 26;5:e1298. doi: 10.1038/cddis.2014.256.

12.

Long noncoding RNA H19 regulates EZH2 expression by interacting with miR-630 and promotes cell invasion in nasopharyngeal carcinoma.

Li X, Lin Y, Yang X, Wu X, He X.

Biochem Biophys Res Commun. 2016 May 13;473(4):913-919. doi: 10.1016/j.bbrc.2016.03.150. Epub 2016 Apr 1.

PMID:
27040767
13.

Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma.

Wang C, Liu X, Chen Z, Huang H, Jin Y, Kolokythas A, Wang A, Dai Y, Wong DT, Zhou X.

Mol Carcinog. 2013 Mar;52(3):229-36. doi: 10.1002/mc.21848. Epub 2011 Dec 7.

14.

The YAP1 oncogene contributes to bladder cancer cell proliferation and migration by regulating the H19 long noncoding RNA.

Li S, Yu Z, Chen SS, Li F, Lei CY, Chen XX, Bao JM, Luo Y, Lin GZ, Pang SY, Tan WL.

Urol Oncol. 2015 Oct;33(10):427.e1-10. doi: 10.1016/j.urolonc.2015.06.003. Epub 2015 Jul 9.

PMID:
26163939
15.

Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines.

Eskander RN, Ji T, Huynh B, Wardeh R, Randall LM, Hoang B.

Int J Gynecol Cancer. 2013 Jul;23(6):997-1005. doi: 10.1097/IGC.0b013e318296a265.

16.

linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer.

He W, Cai Q, Sun F, Zhong G, Wang P, Liu H, Luo J, Yu H, Huang J, Lin T.

Biochim Biophys Acta. 2013 Oct;1832(10):1528-37. doi: 10.1016/j.bbadis.2013.05.010. Epub 2013 May 18.

17.

EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin.

Tong ZT, Cai MY, Wang XG, Kong LL, Mai SJ, Liu YH, Zhang HB, Liao YJ, Zheng F, Zhu W, Liu TH, Bian XW, Guan XY, Lin MC, Zeng MS, Zeng YX, Kung HF, Xie D.

Oncogene. 2012 Feb 2;31(5):583-94. doi: 10.1038/onc.2011.254. Epub 2011 Jun 20.

PMID:
21685935
18.

Methyl jasmonate sensitizes human bladder cancer cells to gambogic acid-induced apoptosis through down-regulation of EZH2 expression by miR-101.

Wang Y, Xiang W, Wang M, Huang T, Xiao X, Wang L, Tao D, Dong L, Zeng F, Jiang G.

Br J Pharmacol. 2014 Feb;171(3):618-35. doi: 10.1111/bph.12501.

19.

NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2.

Hu P, Chu J, Wu Y, Sun L, Lv X, Zhu Y, Li J, Guo Q, Gong C, Liu B, Su S.

Oncotarget. 2015 Oct 20;6(32):32410-25. doi: 10.18632/oncotarget.5609.

20.

Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression.

Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J.

FEBS J. 2013 Apr;280(7):1709-16. doi: 10.1111/febs.12185. Epub 2013 Mar 6.

Supplemental Content

Support Center